ENTERPRISE FINANCIAL SERVICES CORP - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ENTERPRISE FINANCIAL SERVICES CORP ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$0
-100.0%
25
-90.7%
0.00%
-100.0%
Q4 2015$2,0000.0%2700.0%0.00%0.0%
Q3 2015$2,0000.0%2700.0%0.00%0.0%
Q2 2015$2,0000.0%2700.0%0.00%0.0%
Q1 2015$2,0000.0%2700.0%0.00%0.0%
Q4 2014$2,000
+100.0%
270
+592.3%
0.00%0.0%
Q2 2013$1,000390.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$69,390,00026.80%
Opaleye Management Inc. 1,500,000$8,100,000,0006.31%
Camber Capital Management LP 6,000,000$32,400,0003.04%
Ghost Tree Capital, LLC 700,000$3,780,0002.05%
Granite Point Capital Management, L.P. 700,000$3,780,0001.88%
Duquesne Family Office 1,645,000$8,883,0001.09%
Geduld E E 272,200$1,470,0001.04%
Elk Creek Partners, LLC 659,232$3,560,0000.93%
Palo Alto Investors LP 2,231,717$12,051,0000.90%
HighVista Strategies LLC 1,200,000$6,480,0000.87%
View complete list of ARIAD PHARMACEUTICALS INC shareholders